FRANCHISE BRANDS PLC (FRAN) — Investment Research Note

Executive summary

Franchise Brands is an AIM-listed international B2B multi-brand franchisor providing essential van-based services (hydraulic hose replacement via Pirtek, drainage/plumbing via Metro Rod, commercial kitchen filtration via Filta) across 10 countries with a fleet of ~2,500 mobile service vehicles operated by ~265 B2B franchise partners. The trajectory has been transformative acquisition (Filta 2022, Pirtek 2023) followed by two years of subdued organic growth (System sales +2% in FY25) as European industrial end-markets weakened, before a reacceleration in H1 2026 (System sales +6.7%, Adjusted EBITDA +6.5%) driven by Filta North America's Used Cooking Oil ("UCO") tailwind. The single most important valuation point today: strong cash conversion (~80%+) has cut leverage to 1.5x EBITDA and management is on track to return to net cash by 2028, but the FY25 Adjusted EBITDA of £35.2m is materially below the FY27 CMD target of ~£60m — the growth ambition has been recalibrated and the current price already reflects a competent, cash-generative execution story rather than a transformation.

Fair value estimate

• Fair value range: 135p – 175p per share (implied market cap £259m – £335m)
• Methodology: blended EV/EBITDA and P/E multiple on FY26E figures, cross-checked against the deleveraging trajectory.
  • FY26E Adjusted EBITDA: £37m (midpoint of £35.9–38.0m company guidance) 2026-07 interim results
  • Adjusted net debt: £52.9m at H1 2026 2026-07 interim
  • Applying 8.5x–11.0x EV/EBITDA → EV of £315m–£407m → equity £262m–£354m → 137p–185p
  • FY26E Adjusted EPS ~9.6p (H1 4.81p +8.9%) at 15–17x → 144p–163p
  • Central mid: ~155p, implied mcap ~£297m
• Current market cap: £284.5m at 148.5p — sits inside the fair value range, slightly below the mid.
• Absolute upside/downside to mid ~155p: ~+4.4%. Range: ~-9% to +18%.

Sector context

Confirmed ICB classification is Industrials / Industrial Goods & Services (Support Services). Quality/growth profile is above the average UK small-cap industrial services peer thanks to the franchise-fee model's high recurring revenue mix and above-average cash conversion, but organic growth has been below the higher-quality specialty services peers over the last 24 months. Leverage of 1.5x is in line with sector average. Listed peers for reference: Marlowe (compliance services roll-up, similar acquisition-heavy strategy); HomeServe (was) / Pace Global-type essential B2B services; Rentokil Initial (larger, better quality analogue for essential route-density services).

Investment thesis

1. De-gearing accelerates EPS growth mechanically. Adjusted net debt fell from £75m at end-2023 to £52.9m at H1 2026 with leverage down to 1.5x; interest expense fell 16% YoY in H1 26 to £2.6m as the margin dropped from 2.5% to 1.7% and base rates eased. Debt-repayment discipline plus continued cash conversion of ~80%+ should compound EPS growth well above topline for the next 2–3 years 2026-07 interim.
2. Filta International offers genuine structural growth optionality. H1 26 System sales +20% (+24% USD), core franchise sales ex-UCO +13% in local currency, MSF conversion to royalty-only model progressing (77% of System sales now on % royalty), and the new FiltaClean Pro service already licensed by 56% of the North American network in <4 months — a small but under-appreciated growth engine independent of the more cyclical Pirtek book 2026-07 interim.
3. Fair price for a resilient, cash-generative franchise platform. At ~9x forward EV/EBITDA and ~15.5x forward Adjusted P/E, the shares are not demanding for a business with 80%+ recurring/reactive service revenue, an ungeared central cost base, and a progressive dividend policy (interim +9%). Buyback of up to £10m authorised in Jan 2026 provides additional downside support 2026-01 trading update.

Key risks

1. UCO price volatility is masking mediocre organic growth in Europe. H1 26 UCO sales +58% in local currency (16% volume, 36% price); ex-UCO, Filta North America grew 16% and the wider Group's growth would be low-single-digit. A reversion in the UCO price would reveal a business growing ~3% 2026-07 interim.
2. The FY27 £600m System sales / £60m EBITDA CMD ambition set in Feb 2024 is already impaired. FY25 delivered £435m/£35.2m against a plan implying £475m/£45m for that year on the compound trajectory. This is a management-credibility overhang; the 2026-03 final results tacitly walk back the aspiration by refocusing on integration and deleveraging rather than reiterating the numbers 2024-02 CMD vs 2026-03 final results.
3. Pirtek's European industrial exposure remains a headwind. German manufacturing weakness has persisted; H1 26 Pirtek System sales +2%, France DLO -12%. Any deeper Continental industrial recession would eliminate the reacceleration seen in H1 26 2026-07 interim.

Operating leverage

The franchise model has genuine operating leverage at the group cost level but a muted leverage on incremental System sales because most sales sit at the franchisee level, with Franchise Brands capturing only a ~15% Management Service Fee. H1 2026 evidence: System sales +6.7%, gross profit +3.2%, admin expenses +1%, Adjusted EBITDA +6.5%. Admin expenses fell to 11.1% of System sales (11.7% in H1 25). Filta International shows sharpest leverage: US franchisor Adjusted EBITDA +24% on System sales +20% (USD +28% on +24%) 2026-07 interim. A 10–20% System sales beat above current expectations would plausibly add roughly 25–40% to Adjusted EBITDA (not the multi-bagger effect the user seeks from software), because the DLO segments (Willow, Filta UK, Pirtek DLOs) run at only 30–40% gross margin. Fixed-cost inflection points are limited — the "One Franchise Brands" IT consolidation onto NetSuite/HubSpot/Vision will produce incremental cost savings but not a step-change. This is a moderate — not high — operating-leverage story.

Value-trap signals

• Two consecutive years of Adjusted EBITDA effectively flat (£35.1m FY24 → £35.2m FY25) against a CMD growth plan implying strong compounding.
• CFO turnover: Chris Dent (2022) → Mark Fryer (Aug 2023) → Andrew Mallows (interim June 2024, then permanent 2025) → Neil Miller (May 2026). Four CFOs in four years is a governance flag.
• Prior year audit restatement disclosed in the 2024 accounts (2026-06 delayed publication) with multiple IFRS 15 corrections — moderate earnings-quality flag.
• B2C division marketed for sale in 2023, unsold, quietly reintegrated. Suggests strategic drift.
• These are amber flags, not red — none point to structural decline.

Earnings vs. expectations

Across the covered period:

• FY23 (Mar 2024 results, delayed to Jun 2024): Adjusted EBITDA £30.1m vs Jan 2024 guidance range £29.3–£30.1m — met (top end).
• H1 24 (Sep 2024): Adjusted EBITDA £17.8m; full-year guidance narrowed to lower end of £35.7–£37.2m range — implicit downgrade.
• FY24 (Mar 2025): Adjusted EBITDA £35.1m vs Jan 2025 preliminary of £35.5–£36.0m — marginal miss below range.
• FY25 (Mar 2026): Adjusted EBITDA £35.2m vs Nov 2025 range £33.8–£35.3m — met (top end).
• H1 26 (Jul 2026): in-line, FY26 range £35.9–£38.0m reiterated.

Pattern: two negative surprises in FY24 (H1 downgrade and marginal miss), followed by two "meet-top-end" outcomes as management reset expectations lower. Track record is credible but not a serial-beater.

Conviction

Conviction: 3 / 5 (moderate).

• Supporting: clean franchise-fee accounting, 80%+ cash conversion, unambiguous deleveraging trajectory, two convergent valuation methods (EV/EBITDA and P/E) both landing in the 140–175p range.
• Limiting: UCO price is a swing factor of arguably 15–20% of Group profit that I cannot reliably forecast; the CFO churn and CMD walk-back reduce confidence in guidance; European industrial recovery timing is a genuine unknown.